Clinical Study Results
How many participants had serious adverse reactions?
The table below shows the serious adverse reactions that happened during the study.
None of the participants died from serious adverse reactions during the study.
Serious adverse reactions during the study
Dapagliflozin and Dapagliflozin and
saxagliptin placebo Placebo
(out of 152 participants) (out of 145 participants) (out of 148 participants)
Irregular heartbeat 0.7% (1) 0.0% (0) 0.0% (0)
Genital infection 0.0% (0) 0.7% (1) 0.0% (0)
Heart not pumping
blood as well as it 0.0% (0) 0.7% (1) 0.0% (0)
should
Brain damage from
reduced blood flow 0.0% (0) 0.0% (0) 0.7% (1)
in the body
Urinary tract
0.0% (0) 0.0% (0) 0.7% (1)
infection
How many participants had adverse reactions?
The table below shows how many participants had adverse reactions during the study.
Adverse reactions during the study
Dapagliflozin and Dapagliflozin and
saxagliptin placebo Placebo
(out of 152 participants) (out of 145 participants) (out of 148 participants)
How many
participants had
11.8% (18) 14.5% (21) 6.1% (9)
adverse reactions
during the study?
How many
participants had
serious adverse 0.7% (1) 1.4% (2) 1.4% (2)
reactions during
the study?
How many
participants
stopped treatment 3.3% (5) 1.4% (2) 2.7% (4)
because of adverse
reactions?
7